An Interview with Jim Kremidas: What’s Next for the Association of Multisite Research Corporations (AMRC)
Launched in January 2025, the Association of Multisite Research Corporations (AMRC) was set up by its founding members to advance
IRB
Current State of Site-Sponsor-CRO Collaboration
Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.
Ways to Streamline Informed Consent Process in Clinical Trial Startup
At a busy research site, a clinical trial is ready to launch — but it’s stuck in limbo over a
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials Clinical trials are evolving to incorporate adaptive designs, offering flexibility
Demystifying North American IRB/EC Requirements for International Research Professionals
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Solutions For Study Startup
Solutions For Study Startup Study startup in a clinical trial is a critical stage to get your study up and
Choosing Your Electronic IRB System: A Guide for Sites
Selecting an electronic institutional review board (eIRB) system is a critical decision for institutions looking to streamline their research compliance
How Your Study’s Informed Consent Can Help Simplify Study Startup
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Join a Review Committee
REVIEWS Become a Member Join Advarra’s review teams to contribute your expertise to advancing research. Our committees play a vital
Revised Common Rule Reference Guide
The revised Common Rule introduces new exemptions, refined consent elements, and alters IRB oversight for multisite and minimal-risk research.
IRB Information for Participants and Patient Advocacy Groups
Advarra’s institutional review board (IRB) strives to protect participant rights and welfare throughout the research process.
Adapting to the Evolving Era of Oncology: Implications and Strategies for Research Institutions
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.